Our advertisers

Inspiration Healthcare
Medela US
Nutricia Ltd
Vapotherm UK
CliniMed Limited
Nestle SMA
Aspect Imaging
Medacx
Prolacta Bioscience
Lisclare
ParAid

 

 

Volume 16/Issue 3, May 2020

Interruption of high flow nasal oxygen during transfer



A safety critical National Patient Safety Alert has been issued on the risk of harm from interruption of high flow nasal oxygen (HFNO) during transfer. This alert relates to the risk of harm caused by the interruption of HFNO to babies, children and adults in acute respiratory failure without hypercapnia during patient transfer.

Abbreviated: Please subscribe and log in to see the full article.

 
© Copyright of Stansted News Limited 2020. Terms & Conditions of reading. Privacy policy